In August 2025, a large open-air music festival in Denmark became the epicentre of an unusual influenza A(H1N1)pdm09 outbreak. Unlike the typical winter surge, the spike occurred mid-summer – a sixfold increase above baseline – and was traced to attendees of the event. (Source: PMC). This outbreak highlights the need for laboratory networks, diagnostic suppliers, and public health agencies to be prepared and that flu (and other respiratory pathogens) can surprise us outside “typical” seasons, especially in mass gathering settings.
Here’s how diagnostic strategies and product offerings must be prepared, and how Pro-Lab is positioned to support critical surveillance and outbreak management.
While influenza surveillance typically peaks in winter, this event shows viruses can re-emerge during off-peak months if conditions favour transmission (crowds, close contact, shared air). Diagnostic networks and labs must therefore maintain readiness year-round rather than stand down after the “typical flu season.”
Pro-Lab’s response: We maintain inventory and support for respiratory pathogen reagents and kits throughout the year. Our complete range of Viasure PCR and CerTest lateral flow kits are available for labs to deploy at short notice even during off-season surveillance windows.
In the Danish outbreak, the cluster was detected through surveillance systems, then refined via sequencing. But frontline detection is vital to flag anomalies early. Diagnostic tools must be:
Pro-Lab’s response: Our CerTest lateral flow kits provide rapid test options that labs can integrate into their screening workflows. Pair these with confirmatory or subtyping Viasure PCR assays for further characterisation.
Sequence-based surveillance revealed that the outbreak viruses had minimal divergence, consistent with a tight cluster.
Pro-Lab’s Response: We are delighted to have launched the Viasure V-Quick extraction platform compatible with all downstream sequencing platforms. Offering a single workflow for all clinical samples, the platform offers total genomic extraction in just 27 minutes and has capacity for up to 32 samples per run.
Especially during unexpected outbreaks, diagnostic suppliers must be trusted partners. Labs will demand:
Pro-Lab’s response: At Pro-Lab, we emphasise quality, regulatory compliance and service support in every product line. We have a proven track record of supporting the UK and elsewhere during both the SARS-CoV-2 and Mpox outbreaks.
To make adoption easier, Pro-Lab can offer surveillance bundles (e.g. influenza + RSV + SARS-CoV-2 panels) or reagent kits configured for cluster response. Supporting material (protocols, workflows, webinars) can help labs quickly implement out-of-season screening.
The Denmark festival outbreak is a stark reminder that respiratory pathogens do not always adhere to our calendars. Diagnostic readiness, rapid screening, and strategic positioning in mass-gathering contexts are essential.
Pro-Lab is ready to partner with diagnostic labs and public health agencies to provide validated reagents, rapid kits, supportive bundles, and technical support to meet the unexpected.
If you’re planning surveillance or outbreak readiness, get in touch with us to explore tailored diagnostic solutions or field-deployable kits that keep you ahead of the curve whatever the season.
A single-use lateral flow immunoassay designed for the qualitative detection of Influenza A antigens, including subtypes A(H1N1) and A(H3N2), in human nasopharyngeal samples.
Use case: Ideal for point-of-care settings to quickly identify Influenza A infections.
Regulatory Status: CE marked for in vitro diagnostic use.
A single-use lateral flow immunoassay for the qualitative detection of both Influenza A (including subtypes A/H1N1, A/H3N2, A/H5N1) and Influenza B antigens in human nasopharyngeal specimens.
Use Case: Useful in settings where distinguishing between Influenza A and B is necessary.
Regulatory Status: CE marked for in vitro diagnostic use.
A multiplex RT-PCR kit designed for the identification of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus A/B in respiratory samples.
Use Case: Suitable for laboratory settings requiring high sensitivity and specificity to confirm respiratory infections.
Regulatory Status: CE marked and validated according to ISO 13485 standards.
H13 – https://pro-lab.co.uk/product/flu-typing-i-h1n1-h3n2/
HNV – https://pro-lab.co.uk/product/influenza-h1n1/
HXN – https://pro-lab.co.uk/product/flu-typing-ii-h1n1-h5n1-h3n2-h7n9/
RPA – https://pro-lab.co.uk/product/respiratory-viral-panel-i-flu-a-flu-b-rsv-h1n1-h5n1-h3n2-h7n9/
Browse our products at Pro-Lab Diagnostics to learn more about how we can support your lab’s success or contact us today to join our extensive network of labs across the globe.
